Institut* für angewandte Humangenetik und Onkogenetik Professor Froster

Publikationen

1: Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).
Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S; KConFab, Neuhausen SL, Ding YC, Couch FJ, Wang X, Lindor N, Manoukian S, Barile M, Viel A, Tizzoni L, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai P, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H, Weerasooriya N; OCGN, Gerdes AM, Thomassen M, Cruger DG, Caligo MA, Friedman E, Kaufman B, Laitman Y, Cohen S, Kontorovich T, Gershoni-Baruch R, Dagan E, Jernström H, Askmalm MS, Arver B, Malmer B; SWE-BRCA, Domchek SM, Nathanson KL, Brunet J, Ramón Y Cajal T, Yannoukakos D, Hamann U; HEBON, Hogervorst FB, Verhoef S, Gómez García EB, Wijnen JT, van den Ouweland A; EMBRACE, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Cook J, Hodgson S, Morrison PJ, Douglas F, Godwin AK; GEMO, Sinilnikova OM, Barjhoux L, Stoppa-Lyonnet D, Moncoutier V, Giraud S, Cassini C, Olivier-Faivre L, Révillion F, Peyrat JP, Muller D, Fricker JP, Lynch HT, John EM, Buys S, Daly M, Hopper JL, Terry MB, Miron A, Yassin Y, Goldgar D; Breast Cancer Family Registry, Singer CF, Gschwantler-Kaulich D, Pfeiler G, Spiess AC, Hansen TV, Johannsson OT, Kirchhoff T, Offit K, Kosarin K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deissler H, Fiebig B, Varon-Mateeva R, Schaefer D, Froster UG, Caldes T, de la Hoya M, McGuffog L, Antoniou AC, Nevanlinna H, Radice P, Benítez J; CMBA.
Br J Cancer. 2009 Dec 15;101(12):2048-54. Epub 2009 Nov 17.PMID: 19920816 [PubMed - indexed for MEDLINE]

2: Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, Froster UG, Schlehe B, Bechtold A, Arnold N, Preisler-Adams S, Nestle-Kraemling C, Zaino M, Loeffler M, Kiechle M, Meindl A, Varga D, Schmutzler RK.
J Clin Oncol. 2009 Dec 10;27(35):5887-92.

3: New analysis method of myotonic dystrophy 1 based on quantitative fluorescent polymerase chain reaction.
Skrzypczak-Zielinska M, Sulek-Piatkowska A, Mierzejewski M, Froster UG.
Genet Test Mol Biomarkers. 2009 Oct;13(5):651-5.

4: The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Sinilnikova OM, Antoniou AC, Simard J, Healey S, Léoné M, Sinnett D, Spurdle AB, Beesley J, Chen X; kConFab, Greene MH, Loud JT, Lejbkowicz F, Rennert G, Dishon S, Andrulis IL; OCGN, Domchek SM, Nathanson KL, Manoukian S, Radice P, Konstantopoulou I, Blanco I, Laborde AL, Durán M, Osorio A, Benitez J, Hamann U, Hogervorst FB, van Os TA, Gille HJ; HEBON, Peock S, Cook M, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Davidson R, Cole T, Cook J, Paterson J, Brewer C; EMBRACE, Hughes DJ, Coupier I, Giraud S, Coulet F, Colas C, Soubrier F, Rouleau E, Bièche I, Lidereau R, Demange L, Nogues C, Lynch HT; GEMO, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Sutter C, Deissler H, Schaefer D, Froster UG, GC-HBOC, Aittomäki K, Nevanlinna H, McGuffog L, Easton DF, Chenevix-Trench G, Stoppa-Lyonnet D; Consortium of Investigators of Modifiers of BRCA1/2.
Br J Cancer. 2009 Oct 20;101(8):1456-60.

5: New mutation in the CYLD gene within a family with Brooke-Spiegler syndrome.
Scholz IM, Nümann A, Froster UG, Helmbold P, Enk AH, Näher H.
J Dtsch Dermatol Ges. 2009 Jul 24

6: Potential errors with rapid analysis techniques: partial duplication 21q resulting from a paternal paracentric insertion uncovered in chorionic villus sampling by fluorescence in situ hybridization.
Ehrhardt N, Kujat A, Faber R, Horn LC, Froster UG.
Fetal Diagn Ther. 2009;26(4):219-22. Epub 2009 Dec 17.

7. Evaluation of IP-RP-HPLC for length determination of the trinucleotide repeat fragments in Huntington's disease.
Skrzypczak M, Heinritz W, Schulz AM, Mierzejewski M, Froster UG.
J Chromatogr Sci. 2010 Jan;48(1):55-8.

8. New mutation in the CYLD gene within a family with Brooke-Spiegler syndrome.
Scholz IM, Nümann A, Froster UG, Helmbold P, Enk AH, Näher H.
J Dtsch Dermatol Ges. 2010 Feb;8(2):99-101. English, German.

9. A simple method of investigating mutations in CHEK2 by DHPLC: a study of the German populations of Saxony, Saxony-Anhalt, and Thuringia.
Scharrer U, Skrzypczak-Zielinska M, Wituszynska W, Mierzejewski M, Krause K, Cybulski C, Froster UG.
Cancer Genet Cytogenet. 2010 May;199(1):48-52.

>> weiter zu weiteren Publikationen (Seite 1/3)


Institut* für angewandte Humangenetik und Onkogenetik Professor Froster

Badstr. 22
95138 Bad Steben

Anmeldung:
Tel.: 09288 - 5502 999
Fax: 09288 - 957 7104


Privat-Praxis: Kaufmannring 19
04442 Zwenkau

Tel.: 034203 - 4474 200
Fax: 034203 - 4474 280

eMail: praxis@humangenetik-prof-froster.de

*Privatrechtliches Institut Impressum